ATE128358T1 - Therapeutische mittel für diabetisches gangrän. - Google Patents

Therapeutische mittel für diabetisches gangrän.

Info

Publication number
ATE128358T1
ATE128358T1 AT91102606T AT91102606T ATE128358T1 AT E128358 T1 ATE128358 T1 AT E128358T1 AT 91102606 T AT91102606 T AT 91102606T AT 91102606 T AT91102606 T AT 91102606T AT E128358 T1 ATE128358 T1 AT E128358T1
Authority
AT
Austria
Prior art keywords
therapeutic agents
diabetic gangrene
gangrene
diabetic
therapy
Prior art date
Application number
AT91102606T
Other languages
English (en)
Inventor
Masahiko Shikano
Satoshi Tanaka
Masao Ikdea
Hiroshi Nin
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE128358T1 publication Critical patent/ATE128358T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91102606T 1990-02-20 1991-02-22 Therapeutische mittel für diabetisches gangrän. ATE128358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2037284A JPH03240738A (ja) 1990-02-20 1990-02-20 糖尿病性壊疽治療剤
EP91102606A EP0499679B1 (de) 1990-02-20 1991-02-22 Therapeutische Mittel für diabetisches Gangrän

Publications (1)

Publication Number Publication Date
ATE128358T1 true ATE128358T1 (de) 1995-10-15

Family

ID=40202967

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91102606T ATE128358T1 (de) 1990-02-20 1991-02-22 Therapeutische mittel für diabetisches gangrän.

Country Status (13)

Country Link
US (1) US5164373A (de)
EP (1) EP0499679B1 (de)
JP (1) JPH03240738A (de)
KR (1) KR0184008B1 (de)
AT (1) ATE128358T1 (de)
AU (1) AU647078B2 (de)
CA (1) CA2036592C (de)
DE (1) DE69113437T2 (de)
DK (1) DK0499679T3 (de)
ES (1) ES2077698T3 (de)
GR (1) GR3017672T3 (de)
IE (1) IE69393B1 (de)
PT (1) PT96828B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3337488B2 (ja) * 1992-03-06 2002-10-21 アベンティス ファーマ株式会社 切迫流産治療剤
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
WO2003094937A1 (en) * 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
EP2268267B1 (de) * 2008-04-21 2017-06-14 Novo Nordisk Health Care AG Trockene transglutaminase-zusammensetzung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904751A (en) * 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
US3931399A (en) * 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3419581A1 (de) * 1984-05-25 1985-11-28 Behringwerke Ag, 3550 Marburg Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung
JPS63196520A (ja) * 1987-02-09 1988-08-15 Hoechst Japan Kk 潰瘍性大腸炎治療剤
US4904751A (en) * 1987-12-21 1990-02-27 Texaco Chemical Company N,N'-dialkyl substituted polyoxyalklene amines as curing agents for blocked isocyanates
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
IE910565A1 (en) 1991-08-28
KR0184008B1 (ko) 1999-05-01
DE69113437T2 (de) 1996-04-11
CA2036592C (en) 2004-04-06
PT96828B (pt) 1998-07-31
EP0499679A1 (de) 1992-08-26
IE69393B1 (en) 1996-09-18
ES2077698T3 (es) 1995-12-01
JPH0561253B2 (de) 1993-09-06
CA2036592A1 (en) 1991-08-21
PT96828A (pt) 1991-11-29
JPH03240738A (ja) 1991-10-28
GR3017672T3 (en) 1996-01-31
AU647078B2 (en) 1994-03-17
KR910021244A (ko) 1991-12-20
AU7117891A (en) 1991-08-22
US5164373A (en) 1992-11-17
EP0499679B1 (de) 1995-09-27
DK0499679T3 (da) 1996-02-05
DE69113437D1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
GR1000918B (el) Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών.
ATE383167T1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
DE3774918D1 (de) Cancerostatisches mittel.
DE69327432T2 (de) Heilmittel für wunden und hämorrhoiden
DK261490D0 (da) New pharmaceutical compound
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
KR930019224A (ko) 유산 위험 치료제
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
DE3877499T2 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
SE8704093L (sv) Terapeutiska medel och anvendning derav

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time